The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study
Status: | Recruiting |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/15/2019 |
Start Date: | June 27, 2017 |
End Date: | January 2024 |
Contact: | Edwards TMTT Clinical Affairs |
Email: | TMTT_Clinical@edwards.com |
Phone: | +1 949-250-2500 |
The purpose of this study is to assess the safety, performance and clinical outcomes of the
Edwards PASCAL Transcatheter Mitral Valve Repair (TMVr) System.
Edwards PASCAL Transcatheter Mitral Valve Repair (TMVr) System.
The purpose of this study is to assess the safety, performance and clinical outcomes of the
Edwards PASCAL Transcatheter Mitral Valve Repair (TMVr) System. This is a multi-center,
multi-national, prospective, single arm, safety, performance and clinical outcomes study.
Edwards PASCAL Transcatheter Mitral Valve Repair (TMVr) System. This is a multi-center,
multi-national, prospective, single arm, safety, performance and clinical outcomes study.
Inclusion Criteria:
- Signed and dated IRB/ethics committee approved study consent form prior to study
related procedures
- Eighteen (18) years of age or older
- New York Heart Association (NYHA) Functional Class II-IVa heart failure despite
optimal medical therapy
- Candidacy for surgical mitral valve repair or replacement determined by Heart Team
evaluation
- Clinically significant mitral regurgitation (moderate-to-severe or severe mitral
regurgitation) confirmed by transesophageal echocardiography (TEE) and transthoracic
echocardiography (TTE).
- The primary regurgitant jet is non-commissural. If a secondary jet exists, it must be
considered clinically insignificant.
- Mitral valve area (MVA) ≥ 4.0 cm² as measured by planimetry. If MVA by planimetry is
not measurable, pressure half-time measurement is acceptable.
Exclusion Criteria:
- Patient in whom a TEE is contraindicated or screening TEE is unsuccessful
- Leaflet anatomy which may preclude PASCAL device implantation, proper device
positioning on the leaflets, or sufficient reduction in mitral regurgitation.
- Mitral valve area (MVA) < 4.0 cm² as measured by planimetry (If MVA by planimetry is
not measurable, PHT measurement is acceptable)
- Echocardiographic evidence of intracardiac mass, thrombus, or vegetation
- Physical evidence of right sided congestive heart failure and echocardiographic
evidence of severe right ventricular dysfunction
- Concurrent medical condition with a life expectancy of less than 12 months in the
judgment of the Investigator
- Patient is currently participating or has participated in another investigational drug
or device clinical study where the primary study endpoint was not reached at time of
enrollment
- Patient is under guardianship
We found this trial at
9
sites
8700 Beverly Blvd # 8211
Los Angeles, California 90048
Los Angeles, California 90048
(1-800-233-2771)
Principal Investigator: Saibal Kar, MD
Phone: 310-248-8515
Cedars Sinai Med Ctr Cedars-Sinai is known for providing the highest quality patient care. Our...
Click here to add this to my saved trials
1000 Blythe Blvd
Charlotte, North Carolina 28203
Charlotte, North Carolina 28203
(704) 355-2000
Principal Investigator: Michael Rinaldi, MD
Phone: 704-355-4794
Click here to add this to my saved trials
13001 E. 17th Pl
Aurora, Colorado 80045
Aurora, Colorado 80045
303-724-5000
Principal Investigator: John Carroll, MD
Phone: 303-724-6473
University of Colorado Denver The University of Colorado Denver | Anschutz Medical Campus provides a...
Click here to add this to my saved trials
Brisbane, Chermside 4029
Principal Investigator: Darren Walters, MD
Click here to add this to my saved trials
1215 Lee St
Charlottesville, Virginia 22903
Charlottesville, Virginia 22903
(434) 924-0211
Principal Investigator: D. Scott Lim, MD
Phone: 434-982-1058
University of Virginia Health System UVA Health System includes a 604-bed hospital, level I trauma...
Click here to add this to my saved trials
2799 W Grand Blvd
Detroit, Michigan 48202
Detroit, Michigan 48202
(313) 916-2600
Principal Investigator: William O'Neill, MD
Phone: 313-916-7430
Henry Ford Hospital Founded in 1915 by auto pioneer Henry Ford and now one of...
Click here to add this to my saved trials
Evanston, Illinois
Principal Investigator: Ted Feldman, MD
Phone: 847-570-2368
Click here to add this to my saved trials
Morristown, New Jersey 07962
Principal Investigator: Robert Kipperman, MD
Phone: 973-971-4099
Click here to add this to my saved trials
Plano, Texas 75093
Principal Investigator: Robert L Smith, MD
Phone: 469-814-4737
Click here to add this to my saved trials